Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel antiparkinsonian agent displays improved side effect profile

Feb. 26, 1998

Behavioral effects of methylene blue studied in animal models

Feb. 26, 1998

Dolasetron now available in U.S.

Feb. 25, 1998

Lead compound from ABS shows promise for neurodegenerative disorders

Feb. 25, 1998

Another market introduction for Aricept

Feb. 25, 1998

Biogen sets up Canadian office to promote local development of Avonex

Feb. 25, 1998

NOS inhibition with L-NMMA reduces CBF in humans

Feb. 25, 1998

C. pneumoniae antibody titers correlated to stroke and cerebral ischemia

Feb. 25, 1998

T Cell Sciences receives patent on new compound

Feb. 25, 1998

Apollo licenses technologies from U. of Florida

Feb. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...